203 related articles for article (PubMed ID: 34212451)
21. De novo variants in AGO1 recapitulate a heterogeneous neurodevelopmental disorder phenotype.
Niu Y; Qian Q; Li J; Gong P; Jiao X; Mao X; Xiao B; Long L; Yang Z
Clin Genet; 2022 Apr; 101(4):459-465. PubMed ID: 35060114
[TBL] [Abstract][Full Text] [Related]
22. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
[TBL] [Abstract][Full Text] [Related]
23. SCAF4 variants are associated with epilepsy with neurodevelopmental disorders.
Hu Y; Zhang B; Chen L; He J; Yang L; Chen X
Seizure; 2024 Mar; 116():113-118. PubMed ID: 37891035
[TBL] [Abstract][Full Text] [Related]
24. Biallelic variants in
Dentici ML; Alesi V; Quinodoz M; Robens B; Guerin A; Lebon S; Poduri A; Travaglini L; Graziola F; Afenjar A; Keren B; Licursi V; Capuano A; Dallapiccola B; Superti-Furga A; Novelli A
J Med Genet; 2022 Mar; 59(3):262-269. PubMed ID: 33397746
[TBL] [Abstract][Full Text] [Related]
25. Mutations in HECW2 are associated with intellectual disability and epilepsy.
Halvardson J; Zhao JJ; Zaghlool A; Wentzel C; Georgii-Hemming P; Månsson E; Ederth Sävmarker H; Brandberg G; Soussi Zander C; Thuresson AC; Feuk L
J Med Genet; 2016 Oct; 53(10):697-704. PubMed ID: 27334371
[TBL] [Abstract][Full Text] [Related]
26. BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder.
Scott TM; Guo H; Eichler EE; Rosenfeld JA; Pang K; Liu Z; Lalani S; Bi W; Yang Y; Bacino CA; Streff H; Lewis AM; Koenig MK; Thiffault I; Bellomo A; Everman DB; Jones JR; Stevenson RE; Bernier R; Gilissen C; Pfundt R; Hiatt SM; Cooper GM; Holder JL; Scott DA
Hum Mutat; 2020 May; 41(5):921-925. PubMed ID: 31999386
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy.
Luppe J; Sticht H; Lecoquierre F; Goldenberg A; Gorman KM; Molloy B; Agolini E; Novelli A; Briuglia S; Kuismin O; Marcelis C; Vitobello A; Denommé-Pichon AS; Julia S; Lemke JR; Abou Jamra R; Platzer K
Eur J Hum Genet; 2023 Mar; 31(3):345-352. PubMed ID: 36564538
[TBL] [Abstract][Full Text] [Related]
28. Case analysis of epilepsy, neurodevelopmental disorder, and motor disorders associated with mutations in the dehydrodolichyl diphosphate synthase gene.
Lv T; Fu JX; Liu XY; Tang R; Yang GL
Seizure; 2023 Aug; 110():126-135. PubMed ID: 37356182
[TBL] [Abstract][Full Text] [Related]
29. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
[TBL] [Abstract][Full Text] [Related]
30. Connectome Analysis in an Individual with SETD1B -Related Neurodevelopmental Disorder and Epilepsy.
Weng R; Nenning KH; Schwarz M; Riedhammer KM; Brunet T; Wagner M; Kasprian G; Lehrner J; Zimprich F; Bonelli SB; Krenn M
J Dev Behav Pediatr; 2022 Aug; 43(6):e419-e422. PubMed ID: 35385430
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
32. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
[TBL] [Abstract][Full Text] [Related]
33. ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures.
Poggio E; Barazzuol L; Salmaso A; Milani C; Deligiannopoulou A; Cazorla ÁG; Jang SS; Juliá-Palacios N; Keren B; Kopajtich R; Lynch SA; Mignot C; Moorwood C; Neuhofer C; Nigro V; Oostra A; Prokisch H; Saillour V; Schuermans N; Torella A; Verloo P; Yazbeck E; Zollino M; Jech R; Winkelmann J; Necpal J; Calì T; Brini M; Zech M
Genet Med; 2023 Dec; 25(12):100971. PubMed ID: 37675773
[TBL] [Abstract][Full Text] [Related]
34. STXBP6 Gene Mutation: A New Form of SNAREopathy Leads to Developmental Epileptic Encephalopathy.
Vinci M; Costanza C; Galati Rando R; Treccarichi S; Saccone S; Carotenuto M; Roccella M; Calì F; Elia M; Vetri L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003627
[TBL] [Abstract][Full Text] [Related]
35. De novo loss of function mutations in KIAA2022 are associated with epilepsy and neurodevelopmental delay in females.
Webster R; Cho MT; Retterer K; Millan F; Nowak C; Douglas J; Ahmad A; Raymond GV; Johnson MR; Pujol A; Begtrup A; McKnight D; Devinsky O; Chung WK
Clin Genet; 2017 May; 91(5):756-763. PubMed ID: 27568816
[TBL] [Abstract][Full Text] [Related]
36. Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.
Van Dijck A; Vulto-van Silfhout AT; Cappuyns E; van der Werf IM; Mancini GM; Tzschach A; Bernier R; Gozes I; Eichler EE; Romano C; Lindstrand A; Nordgren A; ; Kvarnung M; Kleefstra T; de Vries BBA; Küry S; Rosenfeld JA; Meuwissen ME; Vandeweyer G; Kooy RF
Biol Psychiatry; 2019 Feb; 85(4):287-297. PubMed ID: 29724491
[TBL] [Abstract][Full Text] [Related]
37. [Genetic studies and neurodevelopment. From effectiveness to genetic models].
Calleja-Pérez B; Fernández-Perrone AL; Fernández-Mayoralas DM; Jiménez de Domingo A; Tirado P; López-Arribas S; Suárez-Guinea R; Fernández-Jaén A
Medicina (B Aires); 2020; 80 Suppl 2():26-30. PubMed ID: 32150709
[TBL] [Abstract][Full Text] [Related]
38. De novo variants in DENND5B cause a neurodevelopmental disorder.
Scala M; Tomati V; Ferla M; Lena M; Cohen JS; Fatemi A; Brokamp E; Bican A; Phillips JA; Koziura ME; Nicouleau M; Rio M; Siquier K; Boddaert N; Musante I; Tamburro S; Baldassari S; Iacomino M; Scudieri P; ; Rosenfeld JA; Bellus G; Reed S; Al Saif H; Russo RS; Walsh MB; Cantagrel V; Crunk A; Gustincich S; Ruggiero SM; Fitzgerald MP; Helbig I; Striano P; Severino M; Salpietro V; Pedemonte N; Zara F
Am J Hum Genet; 2024 Mar; 111(3):529-543. PubMed ID: 38387458
[TBL] [Abstract][Full Text] [Related]
39. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
[TBL] [Abstract][Full Text] [Related]
40. U2AF2 variant in a patient with developmental delay, dysmorphic features, and epilepsy.
Kittock CM; Saifeddine M; Straight L; Ward DI
Am J Med Genet A; 2023 Jul; 191(7):1968-1972. PubMed ID: 37092751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
